Related Experiment Video
Updated: Jul 4, 2025
Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Infectious Myelopathies
Objective:
Infectious myelopathy of any stage and etiology carries the potential for significant morbidity and mortality. This article details the clinical presentation, risk factors, and key diagnostic components of infectious myelopathies with the goal of improving the recognition of these disorders and guiding subsequent management.
Latest Developments:
Despite our era of advanced multimodal imaging and laboratory diagnostic technology, a causative organism often remains unidentified in suspected infectious and parainfectious myelopathy cases. To improve diagnostic capability, newer technologies such as metagenomics are being harnessed to develop diagnostic assays with a greater breadth of data from each specimen and improvements in infection identification. Conventional assays have been optimized for improved sensitivity and specificity.
Essential Points:
Prompt recognition and treatment of infectious myelopathy decreases morbidity and mortality. The key diagnostic tools include serologies, CSF analysis, and imaging; however clinical presentation, epidemiologic risk factors, and history of recent illness are all vital to making the proper diagnosis because current laboratory and imaging modalities are often inconclusive. The cornerstone of recommended treatment is targeted antimicrobials with appropriate immune modulation, surgical intervention, supportive care, and interdisciplinary involvement, all of which further improve outcomes for patients with infectious myelopathy.
Insights
Prompt diagnosis and treatment of infectious myelopathy are crucial for reducing patient morbidity and mortality. Early recognition, utilizing clinical presentation and diagnostic tools, guides effective management strategies for these serious spinal cord infections.
Area of Science:
- Neurology
- Infectious Diseases
- Pathology
Background:
- Infectious myelopathy presents a significant risk of morbidity and mortality.
- Accurate diagnosis remains challenging despite advanced technologies.
Purpose of the Study:
- To enhance recognition and management of infectious myelopathies.
- To detail clinical presentation, risk factors, and diagnostic approaches.
Main Methods:
- Review of clinical presentations and diagnostic tools for infectious myelopathies.
- Exploration of advanced diagnostic technologies like metagenomics.
- Emphasis on integrating clinical, epidemiological, and laboratory data.
Main Results:
- Causative organisms are frequently unidentified even with advanced diagnostics.
- Metagenomics offers improved diagnostic breadth and infection identification.
- Conventional assays show optimized sensitivity and specificity.
Conclusions:
- Early recognition and treatment are vital for decreasing morbidity and mortality.
- Diagnosis relies on a combination of clinical, epidemiological, and diagnostic data.
- Treatment involves targeted antimicrobials, immune modulation, and interdisciplinary care for improved outcomes.
Related Concept Videos
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
01:10Intracellular Movement of Viruses and Bacteria